Appl Environ Microbiol. 1995 Jun;61(6):2218-23. doi: 10.1128/aem.61.6.2218-2223.1995.
The bacteria Serratia entomophila and S. proteamaculans cause amber disease in the grass grub, Costelytra zealandica (Coleoptera: Scarabaeidae), an important pasture pest in New Zealand. Disease symptoms include rapid cessation of feeding and amber coloration of larvae. A 105-kb plasmid (designated pADAP) has consistently been found only in pathogenic isolates of both species. Investigations into the involvement of pADAP in amber disease have been hindered by the lack of both a selectable marker on the plasmid and a reliable transposon delivery system. Kanamycin-resistant transposon insertions into three cloned HindIII fragments (9.5, 9.6, and 10.6 kb) were isolated and introduced into pADAP by shuttle mutagenesis. Inserts into the 9.5-and 9.6-kb HindIII fragments on pADAP did not alter disease-causing ability. When plasmids with inserts into the 9.6-kb region were conjugated into plasmid-minus, nonpathogenic isolates of S. entomophila and S. proteamaculans, all of them became pathogenic. Transposon insertions into two regions of the 10.6-kb HindIII fragment continued to cause cessation of feeding but failed to produce amber coloration. Further analysis of a mutant from each amber-minus region (pADK-10 and pADK-13) demonstrated that the antifeeding effect was produced only at dosages higher than that of the wild-type strain. Complementation with the wild-type HindIII fragment restored full-blown disease properties for pADK-13, but not for pADK-10.
节杆菌属的细菌 S. entomophila 和 S. proteamaculans 引起新西兰重要牧草害虫草地贪夜蛾幼虫的琥珀病。疾病症状包括快速停止进食和幼虫呈琥珀色。一种 105kb 的质粒(命名为 pADAP)一直只在这两个种的致病性分离株中发现。由于质粒上缺乏可选择标记和可靠的转座子传递系统,因此对 pADAP 参与琥珀病的研究受到了阻碍。卡那霉素抗性转座子插入三个克隆的 HindIII 片段(9.5、9.6 和 10.6kb)中,并通过穿梭诱变引入 pADAP。插入 pADAP 的 9.5 和 9.6kb HindIII 片段的插入物不会改变致病能力。当带有插入 9.6kb 区域的质粒与无质粒的、非致病性的 S. entomophila 和 S. proteamaculans 分离株进行共轭时,它们都变成了致病性的。转座子插入到 10.6kb HindIII 片段的两个区域继续导致停止进食,但未能产生琥珀色。对每个琥珀色缺失区域(pADK-10 和 pADK-13)的突变体进行进一步分析表明,抗食作用仅在高于野生型菌株的剂量下产生。用野生型 HindIII 片段进行互补恢复了 pADK-13 的全面疾病特性,但对 pADK-10 则没有。